Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer

Bayer, Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor

Ruchika Sharma27 March 2025 9:15 AM IST

Berlin: Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, have announced that they have entered into a global...

DoP hosts industry dialogue on Promotion of Research and Innovation in Pharma-MedTech Sector Scheme at Bengaluru

Ruchika Sharma26 March 2025 5:20 PM IST

New Delhi: The Department of Pharmaceuticals, Government of India, hosted an Industry Dialogue on the scheme for Promotion of Research and...

Over 15000 Jan Aushadhi Kendras opened till last month under PMBJP scheme across country: Minister

Ruchika Sharma26 March 2025 4:15 PM IST

New Delhi: Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme, a total of 15,057 Jan Aushadhi Kendras (JAKs) have been opened till...

Dont throw in the bin, please flush it! CDSCO dictum for these 17 medicines

DoP promotes RnD in Pharma Medtech Sector with AI Integration

Ruchika Sharma26 March 2025 3:30 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has taken steps to promote research and development (R&D) in the sector, including in the areas...

WHO partners with regulators, experts to strengthen safety and access to medical devices

WHO collaborates with regulators, experts to strengthen safety, access to medical devices

Ruchika Sharma26 March 2025 1:15 PM IST

The five-day workshop, held from 17-21 February in Colombo, focused on advancing the safety, quality, and accessibility of medical devices.

Granules India appoints Dr PN Baskaran as President - Head API Manufacturing, Operations

Ruchika Sharma26 March 2025 12:35 PM IST

Telangana: Granules India has announced the appointment of Dr P.N. Baskaran as President - Head API Manufacturing & Operations with effect from...

GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older

Ruchika Sharma26 March 2025 11:15 AM IST

London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa (gepotidacin) for the...

Merck to begin Phase 3 trials for investigational once monthly HIV prevention pill

Merck gets rights to develop, commercialize Jiangsu Hengrui Pharma heart drug worldwide, excluding Greater China region

Ruchika Sharma25 March 2025 5:22 PM IST

The transaction is expected to close in the second quarter of 2025.

Pune Pharmacist Loses Rs 95 Lakh in Medical Store Deal

Novo Nordisk, The United Bio-Technology ink pact for 'triple G' obesity drug

Ruchika Sharma25 March 2025 3:30 PM IST

China: Novo Nordisk and The United Laboratories International Holdings Limited (TUL)'s wholly-owned subsidiary The United Bio-Technology...

USFDA approves Abbott Tendyne to replace mitral valve without open-heart surgery

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in Coronary Artery Disease patients

Ruchika Sharma25 March 2025 2:30 PM IST

Abbott Park: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its...

GSK application to expand use of Nucala for COPD accepted for review by EMA

Ruchika Sharma25 March 2025 1:30 PM IST

IL-5 is a key cytokine (protein) in type 2 inflammation which is an underlying driver in many diseases.

Sanofi earns orphan drug designation for multiple myeloma drug

Sanofi Tolebrutinib under USFDA priority review for multiple sclerosis

Ruchika Sharma25 March 2025 12:15 PM IST

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok